Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2603.00 | 2533.13 | 1.0276 | 1.0518 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2359.00 | 2533.13 | 0.9313 | 0.8706 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 1250.00 | 1210.88 | 2680.00 | 2533.13 | 1.0580 | 1.1087 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2347.00 | 2533.13 | 0.9265 | 0.8617 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 1250.00 | 1210.88 | 1410.00 | 2533.13 | 0.5566 | 0.1537 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2517.00 | 2533.13 | 0.9936 | 0.9880 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 962.00 | 2533.13 | 0.3798 | -0.1943 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2530.00 | 2533.13 | 0.9988 | 0.9977 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2051.00 | 2533.13 | 0.8097 | 0.6403 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2053.00 | 2533.13 | 0.8105 | 0.6418 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2463.00 | 2533.13 | 0.9723 | 0.9480 | |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 1250.00 | 1210.88 | 1344.00 | 2533.13 | 0.5306 | 0.1029 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 1250.00 | 1210.88 | 2813.00 | 2533.13 | 1.1105 | 1.2068 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2711.00 | 2533.13 | 1.0702 | 1.1316 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 1250.00 | 1210.88 | 934.00 | 2533.13 | 0.3687 | -0.2164 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2636.00 | 2533.13 | 1.0406 | 1.0762 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2568.00 | 2533.13 | 1.0138 | 1.0258 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2744.00 | 2533.13 | 1.0832 | 1.1560 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 2847.00 | 2533.13 | 1.1239 | 1.2319 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 1250.00 | 1210.88 | 2375.00 | 2533.13 | 0.9376 | 0.8825 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2627.00 | 2533.13 | 1.0371 | 1.0695 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2797.00 | 2533.13 | 1.1042 | 1.1950 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2488.00 | 2533.13 | 0.9822 | 0.9665 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 2602.00 | 2533.13 | 1.0272 | 1.0510 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2495.00 | 2533.13 | 0.9850 | 0.9717 |